Fundz

Kincell Bio has raised $22M in a funding round led by NewSpring Capital. The funds will enhance its cGMP capabilities and support cell therapy development.

PRIVATEMay 15, 2025

Amount Raised

$22 Million

Round Type

Funding Round

DurhamManufacturingBiotechnology

Investors

NewSpring CapitalKineticos Life Sciences

Description

Kincell Bio, a contract development and manufacturing organization, raised $22M in funding. The round was led by NewSpring Capital with participation from Kineticos Life Sciences. The company plans to use the funds to expand its cGMP capabilities and support innovative cell therapy companies. Pete Buzy has joined Kincell Bio’s Board of Directors as part of this funding.

Quick answer

Kincell Bio raised $22 Million in a Funding Round round, dated May 15, 2025. Investors: NewSpring Capital and Kineticos Life Sciences. Kincell Bio is based in Durham, North Carolina, United States.

How much did Kincell Bio raise?
Kincell Bio raised $22 Million in a Funding Round round on May 15, 2025.
Who invested in Kincell Bio?
NewSpring Capital and Kineticos Life Sciences are named as investors in this round.
What does Kincell Bio do?
Kincell Bio is a technology-forward cell therapy cGMP contract development and manufacturing organization (CDMO) situated in the Southeastern United States.
Where is Kincell Bio based and how big is it?
Kincell Bio is based in Durham, North Carolina, United States. Fundz records about 79 employees.
Who are the decision-makers at Kincell Bio?
Fundz holds 1 contact at Kincell Bio, including the Chief Technology Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Kincell Bio that raised within 45 days of this round, from Fundz verified event records.

  • NewcelX raised $1M (Seed) on June 27, 2025.
  • Hadrian raised $110M on June 27, 2025.
  • Endovia Health Sciences, Inc. raised $33M on June 25, 2025.
  • Elemental Advanced Materials raised $20M (Funding Round) on June 25, 2025.
  • Celltrio raised $15M on June 24, 2025.
  • Celltrio raised $15M (Funding Round) on June 17, 2025.

Who to call at Kincell Bio, and when

A new round usually means Kincell Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kincell Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kincell Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kincell Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kincell Bio

Location

Durham, North Carolina, United States

About

Kincell Bio is a technology-forward cell therapy cGMP contract development and manufacturing organization (CDMO) situated in the Southeastern United States. The company's mission is to streamline CMC development, with expertise in analytical and process development and GMP manufacturing, testing and release.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kincell Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBruce T., Chief Technology OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Kincell Bio's next move

See what Strategic adds

Kincell Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.